Fitzsimon_menu

Innovation is happening. Right here.

Fitzsimons Innovation Community is a sprawling campus of leading-edge laboratory workspace where innovative health and life sciences companies of all sizes take their research to the next level to cure diseases, save lives, and improve care.

Smart, inclusive, forward-thinking, and highly educated people lead life sciences innovation in Colorado, the Hub for Health Impact. Together, we welcome life sciences organizations looking to call Colorado home and to collaborate with a robust community already in on the secret: the health and life sciences industry in Colorado is strong and making a global impact on the future of health.

 Move in, and build your vision here—today.

Community

The emphasis is on Community

We called it a community for a reason. From the board of directors to the newest company on campus, everyone at Fitzsimons Innovation Community knows that easy access to collaboration has direct results on success. From idea incubation to final-product manufacturing, your end-to-end innovation can come alive right here on our campus. All that Colorado sunshine is just a bonus.

Community

Cutting-edge discoveries in action

62%

Companies Hiring

Fitzsimons Innovation Community member companies are thriving. 62% of companies added employees to their workforce.

75%

Companies Fundraising

Most Fitzsimons Innovation Community member companies are actively involved in fundraising to power their progress.

16+

New Innovations

Fitzsimons Innovation Community member companies introduced more than 16 new innovations to the market in 2023.

$116M

Capital Raised

Last year, Fitzsimons Innovation Community member companies attracted more than $116M in investments to support R&D, prepare for clinical trials, accelerate commercialization, and retain or recruit talent.

75%

Companies with Discoveries

Fitzsimons Innovation Community member companies made news with major breakthrough discoveries last year. Areas included molecular biology, pharmaceuticals, medical device, research tools, cell and gene therapy, material science, and diagnostics.

50%

Companies Forging Strategic Partnerships

Fitzsimons Innovation Community member companies forged strategic partnerships for business collaboration, legal services, and venture capital opportunities.

*Fitzsimons Innovation Community Member Growth Survey responses (January – December 2023)

A heritage of healthcare and innovation

Fitzsimons Innovation Community stands on the grounds that once held the Fitzsimons Army Hospital, where soldiers returning from World War I were treated. The Colorado high altitude has always been a destination for advancements in lung treatment, and 100 years ago, soldiers sought cures for tuberculosis and mustard gas exposure right here.

After the Army decommissioned the hospital in the 1990s, ideas for the current University of Colorado Anschutz Medical Campus and Fitzsimons Innovation Community began to percolate. That rich history of discovery, care, and research continues to inspire our vision a century later.

Our team is on your team

You know best when it comes to your projects, and we know how to keep you up and running with first-class scientific facilities management and community engagement. Our priority is to help you thrive on this campus and we have the proven tools and expertise to make that happen.

Ann Dennis

COMMUNITY SERVICE MANAGER

April Giles

Vp, business development

Don Larson

Facilities engineer

Erica N. Slaughenhoup

Accounting Specialist

Julie Ehler

Accounting Lead

Lyle Artz

Site manager

Steve VanNurden

PRESIDENT & CEO

Sue Niblo

Senior property manager

Thomas Smith

Vp, finance & operations

“The workspace has been perfect for our projects, but the most impressive thing to me has been the community. We’ve collaborated with researchers from the CU Anschutz Medical Campus, networked with other Fitzsimons Innovation Community members, and bounced ideas off some of the best minds in healthcare. And it’s all contributed to us moving forward in our research.”

Scott Deeter

CEO, InVitria

“I park my car in the morning, and then I never move it until I leave after work. We walk to lunch and meetings and take advantage of the outdoor space as much as we can during the day. Work-life balance happens right on campus.”

Kristin Nixon

President, PhosphoSolutions

Community

Fitzsimons Innovation Community News

Atara Biotherapeutics
News | Jul 17, 2024

Atara Biotherapeutics

Today Atara announced that the FDA has accepted its Biologics License Application (BLA) and granted Priority Review with a January 15, 2025 hashtag#PDUFA date for tabelecleucel (tab-cel®) as monotherapy for treatment of adult and pediatric patients two years of age and older with Epstein-Barr virus (hashtag#EBV) positive post-transplant lymphoproliferative disease (hashtag#PTLD) who have received at least one prior therapy. For solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate. If approved, tab-cel would be the first approved therapy in the U.S. for EBV+ PTLD. Read the press release for more: https://bit.ly/46bainx

DARTNet enhances and enlarges clinical decision support for clinicians
News | Jul 03, 2024

DARTNet enhances and enlarges clinical decision support for clinicians

DARTNet leaders Wilson Pace and John Westfall co-author "An Exploratory Study of Physician Decision-Making When Treating Uncontrolled COPD" in International Journal of Chronic Obstructive Pulmonary Disease.

Companies selected to present at CBSA’s 2024 Rocky Mountain Life Sciences Investor & Partnering Conference
News | Jul 02, 2024

Companies selected to present at CBSA’s 2024 Rocky Mountain Life Sciences Investor & Partnering Conference

Congratulations to the startup, emerging, and growth companies selected to present at CBSA’s 2024 Rocky Mountain Life Sciences Investor & Partnering Conference, chosen by a panel of experts. Shout out to Fitzsimons Innovation Community Members, EnteroTrack, GelSana, RheumaGen, and Vona Oncology. among those selected.

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute
News | Jul 01, 2024

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute

Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement. Gates Institute will leverage Charles River’s premier cell and gene therapy CDMO expertise to develop Good Manufacturing Practice (GMP)-grade lentiviral vectors (LVVs) for use in novel chimeric antigen receptor (CAR) T-cell therapies for hematological cancers.

Colorado Tech Blog Features GelSana’s Innovative Materials
News | Jul 01, 2024

Colorado Tech Blog Features GelSana’s Innovative Materials

Colorado Tech Spotlight features a profile of GelSana and how this Fitzsimons Innovation Community company is disrupting the field of wound care. Discover how it works, the story behind it, and how the Colorado life sciences and medical technology community comes together to collaborate and grow our state's prominence in the field.

Paving the Way Toward Transplantation: NIH Awards Support Ophthalmology Retinal Research
News | Jun 26, 2024

Paving the Way Toward Transplantation: NIH Awards Support Ophthalmology Retinal Research

CellSight researchers have been granted funding from the National Institutes of Health to better understand retinal cells differentiation and mechanisms for successful stem cell-derived 3D retinal transplants in patients with age-related macular degeneration (AMD).

Expanding the Vision for Fitzsimons Innovation Community
News | Jun 10, 2024

Expanding the Vision for Fitzsimons Innovation Community

Fitzsimons Innovation Community is expanding life sciences innovation in the region with an updated mater plan for the 184-acre innovation campus to the north of the world-renowned University of Colorado Anschutz Medical Center. The innovation community is currently home to more than 80 visionary companies taking their research to the next level to cure disease, save lives and improve care. Centrally located within 20 minutes of Denver International Airport, downtown Denver and the Denver Tech Center, Fitzsimons Innovation Community is custom-built for discovery with state-of-the-art facilities and flex spaces, opportunities for strategic partnerships and collaboration, a broad range of community amenities and the best of the Colorado lifestyle.

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain
News | May 30, 2024

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain

Focusing on non-addictive treatments for chronic pain and addiction, Lohocla Research Corporation gets the go-ahead for first-in-human trials of their first-in-class therapeutic for chronic pain syndromes.

Colorado: Fueling the Future of Life Sciences
News | May 22, 2024

Colorado: Fueling the Future of Life Sciences

A group of 22 partners representing Colorado’s life sciences ecosystem have banded together to fund a new national economic development campaign to bolster Colorado into “America’s epicenter for life sciences innovation.”

CREJ Features Insights from April Giles on Choosing an Innovation Community
News | Apr 16, 2024

CREJ Features Insights from April Giles on Choosing an Innovation Community

For health care and life sciences companies beginning the search for a new facility to call home, innovation communities are often sought-after destinations.

Want to stay on top of what’s happening on campus?

Sign up for regular updates from Fitzsimons Innovation Community.